These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2453974)

  • 1. Inactivation and partition of human immunodeficiency virus during Kistler and Nitschmann fractionation of human blood plasma.
    Hénin Y; Maréchal V; Barré-Sinoussi F; Chermann JC; Morgenthaler JJ
    Vox Sang; 1988; 54(2):78-83. PubMed ID: 2453974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.
    Bos OJ; Sunyé DG; Nieuweboer CE; van Engelenburg FA; Schuitemaker H; Over J
    Biologicals; 1998 Dec; 26(4):267-76. PubMed ID: 10403030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
    Dichtelmüller HO; Biesert L; Fabbrizzi F; Falbo A; Flechsig E; Gröner A; von Hoegen I; Kempf C; Kreil TR; Lee DC; Pölsler G; Roth NJ
    Transfusion; 2011 Jul; 51(7):1412-30. PubMed ID: 21251002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of virus inactivation and removal for the manufacturing procedure of two immunoglobulins and a 5% serum protein solution treated with beta-propiolactone.
    Dichtelmüller H; Rudnick D; Breuer B; Gänshirt KH
    Biologicals; 1993 Sep; 21(3):259-68. PubMed ID: 8117439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of viruses (human immunodeficiency, hepatitis B, vesicular stomatitis and Sindbis viruses) from an intravenous immunoglobulin preparation.
    Hamamoto Y; Harada S; Yamamoto N; Uemura Y; Goto T; Suyama T
    Vox Sang; 1987; 53(2):65-9. PubMed ID: 2825431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma.
    Wells MA; Wittek AE; Epstein JS; Marcus-Sekura C; Daniel S; Tankersley DL; Preston MS; Quinnan GV
    Transfusion; 1986; 26(2):210-3. PubMed ID: 3006303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionation.
    Scheiblauer H; Nübling M; Willkommen H; Löwer J
    Clin Ther; 1996; 18 Suppl B():59-70. PubMed ID: 8930442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of infectious retroviruses during preparation of immunoglobulins.
    Mitra G; Wong MF; Mozen MM; McDougal JS; Levy JA
    Transfusion; 1986; 26(4):394-7. PubMed ID: 3014692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of human immunodeficiency virus in vitro by gossypol.
    Polsky B; Segal SJ; Baron PA; Gold JW; Ueno H; Armstrong D
    Contraception; 1989 Jun; 39(6):579-87. PubMed ID: 2473865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partitioning of TSE infectivity during ethanol fractionation of human plasma.
    Gregori L; Maring JA; MacAuley C; Dunston B; Rentsch M; Kempf C; Rohwer RG
    Biologicals; 2004 Mar; 32(1):1-10. PubMed ID: 15026020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement in the safety of immune globulins prepared from high-risk plasma.
    Gao F; Prince AM; Pascual D; Horowitz B
    Vox Sang; 1993; 64(4):204-9. PubMed ID: 8390765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the virus inactivation capacity of a procedure of human plasma albumin purification by chromatography].
    Stoltz JF; Geschier C; Rivat C; Sertillanges P; Grandgeorges M; Liautaud J; Regnault V; Dumont L
    Ann Pharm Fr; 1993; 51(2):78-93. PubMed ID: 8250488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partitioning and inactivation of viruses during isolation of albumin and immunoglobulins by cold ethanol fractionation.
    Morgenthaler JJ; Omar A
    Dev Biol Stand; 1993; 81():185-90. PubMed ID: 8174802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human immunodeficiency virus (HIV) genome from the lymphocytes of homosexual men.
    Lee YS; Baker L
    J Med Virol; 1987 Dec; 23(4):323-9. PubMed ID: 2447230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion.
    Wittek AE; Phelan MA; Wells MA; Vujcic LK; Epstein JS; Lane HC; Quinnan GV
    Ann Intern Med; 1987 Sep; 107(3):286-92. PubMed ID: 2441634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin.
    Uemura Y; Yang YH; Heldebrant CM; Takechi K; Yokoyama K
    Vox Sang; 1994; 67(3):246-54. PubMed ID: 7863623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.
    Smith MS; Koerber KL; Pagano JS
    J Infect Dis; 1993 Feb; 167(2):445-8. PubMed ID: 7678429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of HIV-1 and HIV-2 by various manufacturing procedures for human plasma proteins.
    Hilfenhaus JW; Gregersen JP; Mehdi S; Volk R
    Cancer Detect Prev; 1990; 14(3):369-75. PubMed ID: 2117485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of particle-associated reverse transcriptase activity in serum from patients with non A - non B hepatitis.
    Sibrowski W; von Wulffen H; Henning H; Laufs R
    Z Gastroenterol; 1987 Oct; 25(10):673-6. PubMed ID: 2446438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kistler/Nitschmann plasma fractionation methods.
    Friedli H; Morgenthaler JJ
    Lancet; 1985 May; 1(8439):1215. PubMed ID: 2860412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.